OBJECTIVE: The purpose of this article is to summarize advances in PET fluorescence resolution, agent design, and preclinical imaging that make a growing case for clinical PET fluorescence imaging. CONCLUSION: Existing SPECT, PET, fluorescence, and MRI contrast imaging techniques are already deeply integrated into the management of cancer, from initial diagnosis to the observation and management of metastases. Combined positron-emitting fluorescent contrast agents can convey new or substantial benefits that improve on these proven clinical contrast agents.
OBJECTIVE: The purpose of this article is to summarize advances in PET fluorescence resolution, agent design, and preclinical imaging that make a growing case for clinical PET fluorescence imaging. CONCLUSION: Existing SPECT, PET, fluorescence, and MRI contrast imaging techniques are already deeply integrated into the management of cancer, from initial diagnosis to the observation and management of metastases. Combined positron-emitting fluorescent contrast agents can convey new or substantial benefits that improve on these proven clinical contrast agents.
Authors: Qinsi Zheng; Manuel F Juette; Steffen Jockusch; Michael R Wasserman; Zhou Zhou; Roger B Altman; Scott C Blanchard Journal: Chem Soc Rev Date: 2014-02-21 Impact factor: 54.564
Authors: Zhibo Liu; Mark Alex Radtke; May Q Wong; Kuo-Shyan Lin; Donald T Yapp; David M Perrin Journal: Bioconjug Chem Date: 2014-09-29 Impact factor: 4.774
Authors: Mary A Hall; Sunkuk Kwon; Holly Robinson; Pier-Anne Lachance; Ali Azhdarinia; Ranjani Ranganathan; Roger E Price; Wenyaw Chan; Eva M Sevick-Muraca Journal: Prostate Date: 2011-05-02 Impact factor: 4.104
Authors: K Perez; R Walsh; K Brilliant; L Noble; E Yakirevich; V Breese; C Jackson; D Chatterjee; V Pricolo; L Roth; N Shah; T Cataldo; H Safran; D Hixson; P Quesenberry Journal: Exp Mol Pathol Date: 2013-03-22 Impact factor: 3.362
Authors: Simon Lindner; Christina Michler; Stephanie Leidner; Christian Rensch; Carmen Wängler; Ralf Schirrmacher; Peter Bartenstein; Björn Wängler Journal: Bioconjug Chem Date: 2014-04-04 Impact factor: 4.774
Authors: Stephan Rogalla; Sebastiaan C M Joosten; Israt S Alam; Sanjiv S Gambhir; Ophir Vermesh Journal: Mol Ther Date: 2018-02-02 Impact factor: 11.454
Authors: Ye Wang; Fei-Fei An; Mark Chan; Beth Friedman; Erik A Rodriguez; Roger Y Tsien; Omer Aras; Richard Ting Journal: J Cereb Blood Flow Metab Date: 2017-01-05 Impact factor: 6.200
Authors: Harikrishna Kommidi; Umberto Tosi; Uday B Maachani; Hua Guo; Christopher S Marnell; Benedict Law; Mark M Souweidane; Richard Ting Journal: ACS Med Chem Lett Date: 2018-01-17 Impact factor: 4.345
Authors: Hongping Deng; Christian J Konopka; Tzu-Wen L Cross; Kelly S Swanson; Lawrence W Dobrucki; Andrew M Smith Journal: ACS Nano Date: 2020-01-07 Impact factor: 15.881
Authors: Hua Guo; Harikrishna Kommidi; Uday B Maachani; Julia C Voronina; Weiqi Zhang; Rajiv S Magge; Jana Ivanidze; Amy P Wu; Mark M Souweidane; Omer Aras; Richard Ting Journal: Mol Pharm Date: 2019-07-10 Impact factor: 5.364
Authors: Zhi Lu; Truc Thuy Pham; Vineeth Rajkumar; Zilin Yu; R Barbara Pedley; Erik Årstad; John Maher; Ran Yan Journal: J Med Chem Date: 2018-02-06 Impact factor: 7.446